5 rezultātiem
BACKGROUND OF THE INVENTION
Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants
BACKGROUND OF THE INVENTION
Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants
BACKGROUND OF THE INVENTION
Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants
FIELD OF THE INVENTION
This invention relates to the field of antiinflammatory drugs and compositions that prevent reduce or reverse the gastrointestinal, renal and other toxicities associated with antiinflammatory agents, and at the same time provide additional tissue protection.
STATEMENT
TECHNICAL FIELD
The present invention relates to a method and a medicament for treating or preventing a disease. More particularly, the present invention relates to a method and a medicament for treating or preventing a disease using cognition of the cerebrum.
BACKGROUND ART
(Structure of Brain)
A